Search - tctmd.com

Displaying 61 - 80 of 536

Sort: Relevancy | Date

News Conference News AHA 2024

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

Shelley Wood

November 16, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

Todd Neale

October 15, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

L.A. McKeown

July 02, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

Todd Neale

June 24, 2024

News Daily News

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

L.A. McKeown

June 13, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

Advertisement

Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F

Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

October 2024 Dispatch for the CV Team

Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction

AHA Statement Outlines Cardiac Contributions to Brain Health

Will Semaglutide Change Cardiac Surgery? It Already Has

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

August 2024 Dispatch for the CV Team

Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Aspirin for Primary Prevention of CVD Remains Common in US

Remote Monitoring May Curb Recurring BP Problems of Pregnancy

AHA Celebrates a Century by Looking Back, and Forward

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content